Amyotrophic lateral sclerosis (ALS) is probably one of the most devastating diagnoses that we should all hope to never hear. Also known as Lou Gehrig's disease, or motor neuron disease, ALS is a prog ...

Nicholas R. Metrus, MD, is a neurologist and neuro-oncologist with Atlantic Health System. He has completed research on complications of cancer and primary brain tumors like hypermutator gliomas that ...

The Food and Drug Administration (FDA) has not approved stem cell therapy for amyotrophic lateral sclerosis (ALS). However, people could participate in clinical trials involving this ALS treatment.

Amyotrophic lateral sclerosis (ALS) is a life-threatening neurodegenerative disorder with a two- to three-year median survival after the appearance of symptoms. ALS mainly affects upper and lower ...

The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...

A Northwestern Medicine study has shed light on a critical molecular mechanism underlying amyotrophic lateral sclerosis (ALS) ...

NUZ-001, an investigational oral therapy for ALS, is officially the ninth compound to be included in the HEALEY ALS platform ...

Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a progressive neurodegenerative disease. It affects your nerves and muscle tissue and worsens over time, eventually becoming fatal.

Amyotrophic lateral sclerosis (ALS) is a progressive neurological condition that eventually results in the loss of the ability to walk, talk, and swallow. In most cases, the cause of ALS is unknown.